Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1468062
PUBLISHER: IMARC | PRODUCT CODE: 1468062
Alpha Emitter Market Report by Type of Radionuclide, Medical Application, End User, and Region 2024-2032
PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global alpha emitter market size reached US$ 1,476.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,975.8 Million by 2032, exhibiting a growth rate (CAGR) of 24.22% during 2024-2032.
Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.
Alpha Emitter Market Trends:
The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global alpha emitter market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type of radionuclide, medical application, and end user.
Breakup by Type of Radionuclide:
Astatine
Radium
Actinium
Lead
Bismuth
Others
Breakup by Medical Application:
Prostate Cancer
Bone Metastasis
Ovarian Cancer
Pancreatic Cancer
Endocrine Tumors
Others
Breakup by End User:
Hospitals
Medical Research Institutions
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.
Key Questions Answered in This Report
- 1. What was the size of the global alpha emitter market in 2023?
- 2. What is the expected growth rate of the global alpha emitter market during 2024-2032?
- 3. What are the key factors driving the global alpha emitter market?
- 4. What has been the impact of COVID-19 on the global alpha emitter market?
- 5. What is the breakup of the global alpha emitter market based on the type of radionuclide?
- 6. What is the breakup of the global alpha emitter market based on the medical application?
- 7. What are the key regions in the global alpha emitter market?
- 8. Who are the key players/companies in the global alpha emitter market?
Product Code: SR112024A6398
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Alpha Emitter Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type of Radionuclide
- 6.1 Astatine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Radium
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Actinium
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Lead
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Bismuth
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Medical Application
- 7.1 Prostate Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bone Metastasis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Ovarian Cancer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pancreatic Cancer
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Endocrine Tumors
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Medical Research Institutions
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Actinium Pharmaceuticals Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Alpha Tau Medical Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bayer AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Fusion Pharmaceuticals
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 IBA RadioPharma Solutions
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 RadioMedix Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.1 Actinium Pharmaceuticals Inc.
Product Code: SR112024A6398
List of Figures
- Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
- Figure 2: Global: Alpha Emitter Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2023
- Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2023
- Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2023
- Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2023
- Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: North America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: United States: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: China: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: India: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: France: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2023
- Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
- Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
- Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million US$), 2024-2032
- Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million US$), 2024-2032
- Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Alpha Emitter Market: Competitive Structure
- Table 7: Global: Alpha Emitter Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.